The IDR Battleground: When Insurers Lose in Court, Who Actually Gets Paid? 

No Surprises Act · Independent Dispute Resolution · Provider Finance 

By Olga Khabinskay, Director of Operations, WCH 

Blue Cross just lost in both Texas and California. The courts are closing off the litigation escape route. But for small independent practices still waiting on arbitration awards, the real crisis is not legal — it is financial survival. 

When a federal magistrate judge in California dismissed Anthem Blue Cross’s lawsuit against billing intermediary HaloMD on April 9, 2026, the ruling landed like a verdict on an entire insurance industry strategy. In a sweeping 22-page order, Judge Karen Scott found that Anthem had no legal foundation for using RICO claims, ERISA arguments, and fraud theories to retroactively nullify independent dispute resolution (IDR) awards it simply did not want to pay. A nearly identical outcome had already played out in Texas. The message from the bench was unambiguous: Congress designed the No Surprises Act’s IDR process to be final. It is not an invitation for a second round of litigation. 

Yet a crucial question hangs over the entire episode — and it is not the one the insurers were asking. The real question is this: if large, well-capitalized health systems and PE-backed physician groups are forced to file lawsuits just to collect money they have already won in arbitration, what hope exists for a three-physician independent practice in rural Ohio or a solo anesthesiologist in suburban Texas? 

1.2M New IDR disputes filed in H1 2025 alone

88% Provider win rate in resolved IDR cases, H1 2025

24% IDR awards not paid on time or in full, per 2024 physician survey

The Litigation Playbook Runs Out of Pages 

To understand the significance of the California and Texas dismissals, it helps to understand what insurers were actually attempting. Anthem accused HaloMD of obtaining inflated reimbursements through the NSA’s IDR system, alleging violations including mail and wire fraud. The company argued it was seeking judicial review of what it called systemic “schemes,” not any individual IDR payment determination. The argument was creative. If insurers could characterize mass arbitration submissions as a coordinated fraud, they might drag the entire IDR outcome pool into federal court and effectively freeze hundreds of millions in owed payments. 

The courts were unconvinced. Judge Scott wrote that Elevance failed to present convincing evidence that the defendants had willfully committed fraud, and her ruling threw cold water on insurers’ ability to turn to courts to contest IDR determinations altogether. In California’s Central District, every single one of Anthem’s claims — RICO, ERISA, fraud, state law — was dismissed with no leave to amend. The court held that the NSA’s limitations on judicial review preclude courts from second-guessing IDR eligibility and award determinations, calling one of Anthem’s arguments “a novel argument unsupported by any case law.” 

With similar lawsuits still pending in Georgia and Ohio, the California and Texas outcomes create significant headwinds for payers hoping courts will do what arbitrators would not: rule for the insurer. As HaloMD’s general counsel noted after the ruling, allowing insurers to relitigate every unfavorable arbitration outcome in federal court would completely undermine congressional intent. 

“If large hospital systems are struggling to fight insurer denials and unpaid awards, small independent practices — with a fraction of the resources — face a near-impossible climb.” 

The Systemic Problem the Lawsuits Reveal 

The insurer litigation strategy, whatever its merits, exposed something important about the IDR ecosystem: a significant share of awarded payments are simply not being made on schedule. A 2024 physician association survey found that 24% of IDR payments awarded to members either were not paid within the required 30-business-day timeframe or were not paid in full. That is not a rounding error. For a practice that entered IDR specifically because it could not collect fair reimbursement through normal channels, waiting months beyond an arbitration win compounds the injury. 

The scale of the IDR system has grown far beyond anyone’s projections. When federal agencies modeled the IDR process, they expected approximately 22,000 disputes annually. In the first six months of 2025 alone, parties submitted 1.2 million new disputes to the portal — more than double the volume of the first two quarters of 2024. That backlog pressure creates its own form of delay. Arbiters are processing more cases than ever, but eligibility reviews remain the primary source of slowdown, and about 20% of disputes submitted in the first half of 2025 were actually ineligible for IDR. 

Meanwhile, the financial strain on providers who must wait is accumulating in real time. Even as overall healthcare Chapter 11 filings fell in 2025, hospital bankruptcies rose, suggesting many hospitals remain financially fragile. Hospital claim denials and audits increased in 2025, with insurers citing rising costs as the basis for approximately 18% national premium increases projected for 2026. The math is grim: reimbursement disputes are escalating precisely as providers’ operating margins compress. 

The Small Practice Problem Is Structural 

Large organizations like HaloMD and Radiology Partners can play offense at scale. They have legal teams, analytics infrastructure, and the cash flow to absorb months of non-payment while litigation unfolds. As of April 2026, federal courts remain split on whether the No Surprises Act even contains a private right of action that allows providers to enforce IDR awards in court at all. Some courts say yes; others say no. That legal uncertainty is itself a form of leverage for payers, because it forces providers to calculate whether fighting for collections is worth the litigation cost. 

For a 10-person cardiology group or an independent radiology practice, that calculation is brutal. Filing IDR disputes requires administrative resources — understanding eligibility rules, assembling documentation, tracking timelines, paying filing fees. Winning the dispute is only the beginning. If the payer delays payment or disputes the award, a small practice faces the choice of absorbing the loss or initiating federal litigation with uncertain odds and certain costs. The disputes between large hospital systems and insurers — Mount Sinai alone claims Anthem owes it more than $450 million in unpaid claims — illustrate that even major providers are fighting hard for money they are owed. Independent practices do not have the brand leverage, the patient volume leverage, or the legal budget to replicate that fight. 

The courts are now making clear that the IDR process is meant to be the final word. That is, in principle, good news for providers — it closes the insurer litigation escape hatch. But “final and binding” only matters if payment actually follows. The enforcement gap remains real, and it falls hardest on those least equipped to close it. 

What Needs to Happen Next 

The court rulings in California and Texas should be the beginning of accountability, not the end of the story. Several things need to change for the IDR system to function as Congress intended. First, steeper penalties for late or incomplete payment of IDR awards are essential. The current Congress has introduced bipartisan legislation including provisions for stronger penalties against insurers that fail to issue timely and accurate payments after an IDR decision, though its prospects remain uncertain. Second, the private right of action question needs legislative resolution — providers should not have to litigate whether they can litigate. Third, transparency around Qualified Payment Amounts must improve so that providers can make informed decisions about whether to enter IDR at all. 

Until those structural improvements materialize, independent practices need to approach revenue cycle management with the same strategic sophistication that large groups deploy. That means meticulous claim documentation, rigorous tracking of payment timelines after IDR determinations, and proactive escalation before accounts age past recovery. It means knowing exactly when the 30-business-day payment clock expires and having a documented protocol for what happens next. Winning an arbitration award and then leaving the collection to chance is not a revenue strategy — it is a donation to the payer’s cash flow. 

Independent Practices Deserve Professional-Grade Revenue Cycle Support 

At WCH Service Bureau, we work exclusively with independent and small-group medical practices — the providers who are most vulnerable to the exact dynamics described in this article. Our billing specialists understand IDR timelines, payer escalation protocols, and the documentation standards that protect your claims from the start. 

When an arbitration award is won, we make sure it is actually collected. When a claim is denied, we work the appeal. When the system is stacked against a small practice, we provide the infrastructure to push back effectively. 

If the landscape described above concerns you — it should. Reach out to WCH to discuss how professional revenue cycle management can protect your practice’s financial health in an increasingly adversarial reimbursement environment. 

Sources: 

1. Healthcare Finance News — Elevance subsidiary No Surprises Act lawsuit dismissed https://www.healthcarefinancenews.com/news/elevance-subsidiary-no-surprises-act-lawsuit-dismissed 

2. Healthcare Dive — California judge tosses Elevance’s surprise billing suit in win for providers https://www.healthcaredive.com/news/elevance-surprise-billing-suit-tossed-california-halomd/817405/ 

3. Becker’s Payer Issues — California judge dismisses Elevance’s No Surprises Act lawsuit against HaloMD https://www.beckerspayer.com/legal/california-judge-dismisses-elevances-no-surprises-act-lawsuit-against-halomd/ 

4. STAT News — Federal judge tosses California No Surprises Act lawsuit against HaloMD https://www.statnews.com/2026/04/13/halo-md-no-surprises-act-lawsuit-blue-cross-california/ 

5. TechTarget / RevCycle Management — Judge dismisses No Surprises Act lawsuit against HaloMD https://www.techtarget.com/revcyclemanagement/news/366641627/Judge-dismisses-No-Surprises-Act-lawsuit-against-HaloMD 

6. PR Newswire / HaloMD — California Federal Court Delivers Landmark Victory for Healthcare Providers in No Surprises Act Dispute https://www.prnewswire.com/news-releases/california-federal-court-delivers-landmark-victory-for-healthcare-providers-in-no-surprises-act-dispute-302740357.html 

7. Georgetown University O’Neill Institute — First Two Court Decisions in Insurer Lawsuits Under the No Surprises Act https://oneill.law.georgetown.edu/california-court-issues-first-decision-in-insurer-lawsuits-under-the-no-surprises-act/ 

8. Georgetown CHIR / Health Affairs — The No Surprises Act IDR Process: An Early Look at 2025 Data https://chir.georgetown.edu/the-no-surprises-act-idr-process-an-early-look-at-2025-data/ 

9. HFMA — No Surprises Act Arbitration Has Been a Bonanza for a Few Provider Groups https://www.hfma.org/payment-reimbursement-and-managed-care/no-surprises-act-arbitration-has-been-a-bonanza-for-a-few-provider-groups/ 

10. Healthcare Dive — No Surprises Disputes Increasing Even as Arbiters Catch Up, CMS Says https://www.healthcaredive.com/news/no-surprises-disputes-idr-2025-cms/810525/ 

11. NBC News — Hospitals and Insurers Are Fighting Over Money, Leaving Patients in the Lurch https://www.nbcnews.com/health/health-news/hospitals-insurers-dispute-contract-patients-lurch-rcna258248 

12. Medical Economics — Health Care Bankruptcies Drop in 2025, But That Doesn’t Mean All Is Well for 2026 https://www.medicaleconomics.com/view/health-care-bankruptcies-drop-in-2025-but-that-doesn-t-mean-all-is-well-for-2026 

13. Staffing Industry Analysts — US Hospitals Are Emerging from Bankruptcy Only to Falter Again https://www.staffingindustry.com/news/global-daily-news/us-hospitals-are-emerging-from-bankruptcy-only-to-falter-again